WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6601 Infant (under 12 months) mortality rate: 382
GDP / capita (US$): 1'7171 Child (under 5 years) mortality rate: 552

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 39'032  37'783  36'573  35'401  34'260  23'758  17'384  12'548 
Births 1'665  1'630  1'595  1'560  1'526  1'155  866  617 
Surviving infants 1'568  1'533  1'498  1'464  1'430  1'052  768  548 
Pop. less than 5 years 7'278  7'105  6'941  6'779  6'615  4'726  3'421  2'438 
Pop. less than 15 years 18'771  18'259  17'749  17'242  16'737  11'710  8'352  5'950 
Female 15-49 years 8'699  8'367  8'050  7'749  7'461  5'085  3'796  2'731 

Number of reported cases

(Click for retrospective incidence data for Uganda)
Diphtheria
ChartChart
  95  181 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  61'918  314  7'878  2'027  3'312  42'554  2'637  13'415 
Mumps
ChartChart
 
Pertussis
ChartChart
  913  2'122 
Polio*
ChartChart
  28  37 
Rubella
ChartChart
  1'055  291  7'878  2'027  3'312 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  134  84  406  149  207  470  129 
Tetanus (total)**
ChartChart
  1'804  1'358  2'928  1'019  623  710  288  48 
Yellow fever
ChartChart
  32  66 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Uganda)
Vaccine year result method % card seen                                                
BCG 2011  97  EPI   79  95  90  94  82  86  83  99* 
DTP1 2011  96  EPI   79  97  99  99*  89  91  72 
DTP3 2011  92  EPI   79  89  99  97  78  82  58  77 
DTP4         
IPV1         
HepB_BD         
HepB3 2004  76  EPI   73  89  99  97  78  82 
Hib3 2004  76  EPI   73  89  99  97  78  82 
JapEnc         
MCV1          94  96  97  82  75  61  74 
MCV2         
PCV1          88  96 
PCV3          77  50 
Pol3 2010  63  DHS   59  92  99  99  82  82  57  77 
Rota1         
RotaC         
Rubella1         
TT2plus 2010  56  DHS   59  58  56  56  49  49  42  31 
PAB         
VAD1          55  24  59  56 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Uganda)
BCG
ChartChart
  93  93  93  93  97  82  75 
DTP1
ChartChart
  89  89  89  89  91  80  72 
DTP3
ChartChart
  78  78  78  78  82  52  45 
HepB3
ChartChart
  78  78  78  78  82 
HepB_BD
ChartChart
 
Hib3
ChartChart
  78  78  78  78  82 
IPV1
ChartChart
 
MCV1
ChartChart
  82  82  82  82  75  57  52 
MCV2
ChartChart
 
PAB
ChartChart
  85  85  85  85  85  70  41 
PCV3
ChartChart
  66  50 
Pol3
ChartChart
  82  82  82  82  82  55  45 
RCV1
ChartChart
 
RotaC
ChartChart
 
YFV
ChartChart
 

Number of districts in the country 112  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 71
From 80 to 89% 19
From 50 to 79% 11
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years; +6 months; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
TT 15 years; +4 weeks;+6 weeks; +1, +1 year; Yes 15-45 years
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2011-2014  2010-2014  2010 - 2014  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 112  55  39  80  80  80 

System performance

Total Nº districts in country number 112  112  112  112  80  80  80 
Nº districts with DTP3 coverage >=80% number 96  93  47  66    47  16 
% of districts with DTP3 coverage >=80% From 0 to 100% 86  83  42  59    59  20 
Nº districts with measles (MCV1) coverage >=95% number 52  50  34  17  11  13   
% of districts with MCV1 coverage >=95% From 0 to 100% 46  45  30  15  14  16   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 49  24    100  21  21  60 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.